Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
11	September 30, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress DUBLIN, Calif., Sept. 30, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a ph Add to Reading List Source URL: astx.com Language: English Biomarker Medicine Astex Acute myeloid leukemia
12	Astex Pharmaceuticals to Announce 2011 Fourth Quarter and Year-End Financial Results on March 5, 2012 DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the Add to Reading List Source URL: astx.com Language: English
13	July 29, 2013 Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company d Add to Reading List Source URL: astx.com Language: English
14	Astex Receives Milestone from Wellcome Trust for Pioneering HCV Research Cambridge, UK, 1st February 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, an Add to Reading List Source URL: astx.com Language: English Health in the United Kingdom Science and technology in the United Kingdom Cambridge Science Park Hepatitis C virus Wellcome Trust Hepatitis C Medical research United Kingdom Astex Health
15	News Release Astex Pharmaceuticals Reports 2012 Second Quarter Financial Results Dacogen Royalty Revenue Increased 25% from Prior Year $5.4 Million Earned on Phase I Trial Initiation of FGFR Kinase Inhibitor Dacogen Rece Add to Reading List Source URL: astx.com Language: English Generally Accepted Accounting Principles Pharmacology Taxation Financial statements Pharmaceutical industry Astex Income tax in the United States Balance sheet Amortization Accountancy Business Finance
16	April 10, 2013 Astex Pharmaceuticals Provides SGI-110 Update Oral Presentation at AACR Supports Potential of SGI-110 In The Treatment Of Platinum-Resistant Ovarian Cancer Clinical Update on SGI[removed]Study DUBLIN, Cali Add to Reading List Source URL: astx.com Language: English Alkylating antineoplastic agents Acute leukemia Acute myeloid leukemia Myeloid leukemia Myelodysplastic syndrome Carboplatin Chemistry Oncology Medicine
17	Astex Announces Milestone in Oncology Collaboration Cambridge, UK, 11 January 2011 Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has rec Add to Reading List Source URL: astx.com Language: English Cell cycle Tumor suppressor genes Transcription factors Astex Cyclin-dependent kinase P16 Retinoblastoma protein Cyclin Melanoma Biology Cell biology Proteins
18	September 6, 2012 Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration DUBLIN, Calif., and CAMBRIDGE, UK, Sept. 6, 2012 (GLOBE NEWSWIRE) Add to Reading List Source URL: astx.com Language: English Institute of Cancer Research Astex Cancer research Cancer Research UK American Association for Cancer Research Medicine Cancer organizations Oncology
19	Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc Add to Reading List Source URL: astx.com Language: English Myelodysplastic syndrome Syndromes Acute myeloid leukemia Eisai Neutropenia Decitabine Anemia Medicine Oncology Health
20	Astex Pharmaceuticals Reports 2012 First Quarter Financial Results Reports First Quarter Net Income of $4.2 Million Dacogen Royalty Revenue Increases 21% from Prior Year Ends First Quarter with $126 Million in Cash & Mar Add to Reading List Source URL: astx.com Language: English Generally Accepted Accounting Principles Taxation Balance sheet Amortization Deferral Astex Income tax in the United States Goodwill Valuation Accountancy Finance Business